Skip to main content
. 2015 Jul 1;6(4):308–318. doi: 10.6004/jadpro.2015.6.4.2

Figure 1.

Figure 1

Oncology nurse respondents’ (A) injection-site selection, (B) injection-site preference, and (C) correlation between injection-site preference and facility layout, for administration of subcutaneous bortezomib (p = .02, based on Fisher’s exact test).